(Q28343880)

English

Prostate cancer treated by anti-androgens: is sexual function preserved? EORTC Genitourinary Group. European Organization for Research and Treatment of Cancer

scientific article

In more languages

default for all languages

No label defined

No description defined

Statements

scholarly article

0 references

Prostate cancer treated by anti-androgens: is sexual function preserved? EORTC Genitourinary Group. European Organization for Research and Treatment of Cancer (English)

0 references

prostate cancer

1 reference

based on heuristic

inferred from title

author name string

F H Schröder

1

0 references

L Collette

2

0 references

T M de Reijke

3

0 references

P Whelan

4

0 references

language of work or name

0 references

publication date

January 2000

0 references

British Journal of Cancer

0 references

82

0 references

2

0 references

283-90

0 references

Serum concentrations of prostate specific antigen and its complex with alpha 1-antichymotrypsin before diagnosis of prostate cancer

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2363280

29 September 2017

Treatment of advanced prostatic cancer with parenteral cyproterone acetate: a phase III randomised trial

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2363280

29 September 2017

Evaluation of survival data and two new rank order statistics arising in its consideration

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2363280

29 September 2017

Sexual dysfunction associated with the management of prostate cancer

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2363280

2 June 2018

Are non-steroidal anti-androgens appropriate as monotherapy in advanced prostate cancer?

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2363280

2 June 2018

Comparison of diethylstilbestrol, cyproterone acetate and medroxyprogesterone acetate in the treatment of advanced prostatic cancer: final analysis of a randomized phase III trial of the European Organization for Research on Treatment of Cancer Urol

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2363280

2 June 2018

'Potency': the validation of information from a self-administered questionnaire using objective measurements of night-time erections and test-retest reliability

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2363280

27 November 2018

Maximum androgen blockade using LHRH agonist buserelin in combination with short-term (two weeks) or long-term (continuous) cyproterone acetate is not superior to standard androgen deprivation in the treatment of advanced prostate cancer. Final anal

1 reference

https://pubmed.ncbi.nlm.nih.gov/10646878

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Flutamide versus stilboestrol in the management of advanced prostatic cancer. A controlled prospective study

1 reference

https://pubmed.ncbi.nlm.nih.gov/10646878

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Impotence in older men

1 reference

https://pubmed.ncbi.nlm.nih.gov/10646878

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Sexual function in the elderly

1 reference

https://pubmed.ncbi.nlm.nih.gov/10646878

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Impotence and its medical and psychosocial correlates: results of the Massachusetts Male Aging Study

1 reference

https://pubmed.ncbi.nlm.nih.gov/10646878

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Intermittent androgen suppression in the treatment of prostate cancer: a preliminary report

1 reference

https://pubmed.ncbi.nlm.nih.gov/10646878

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Bilateral orchiectomy with or without flutamide for metastatic prostate cancer

1 reference

https://pubmed.ncbi.nlm.nih.gov/10646878

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

The final analysis of the EORTC Genito-Urinary Tract Cancer Co-Operative Group phase III clinical trial (protocol 30805) comparing orchidectomy, orchidectomy plus cyproterone acetate and low dose stilboestrol in the management of metastatic carcinom

1 reference

https://pubmed.ncbi.nlm.nih.gov/10646878

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

High-dose bicalutamide monotherapy for the treatment of prostate cancer

1 reference

https://pubmed.ncbi.nlm.nih.gov/10646878

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Experience with flutamide in patients with advanced prostatic cancer without prior endocrine therapy

1 reference

https://pubmed.ncbi.nlm.nih.gov/10646878

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Identifiers

10.1054/BJOC.1999.0916

0 references

Dimensions Publication ID

0 references

PMC publication ID

0 references

PubMed publication ID

0 references

ResearchGate publication ID

0 references

Sitelinks

Wikipedia(0 entries)

Wikibooks(0 entries)

Wikinews(0 entries)

Wikiquote(0 entries)

Wikisource(0 entries)

Wikiversity(0 entries)

Wikivoyage(0 entries)

Wiktionary(0 entries)

Multilingual sites(0 entries)

Retrieved from "https://www.wikidata.org/w/index.php?title=Q28343880&oldid=2175245551"